Aldeyra Therapeutics, Inc.
ALDX
$5.88
$0.254.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.03% | -22.86% | -232.61% | -84.60% | -87.47% |
| Total Depreciation and Amortization | 1.14% | 0.50% | -3.16% | -3.08% | -4.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -112.60% | 31.11% | 215.41% | 211.21% | -13.50% |
| Change in Net Operating Assets | -36.97% | -40.27% | -51.57% | 648.12% | 134.60% |
| Cash from Operations | 35.31% | -25.04% | -2,505.44% | 0.62% | 1.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.96% | 124.00% | -- | -- | -- |
| Cash from Investing | 96.96% | 124.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 71.94% | -- | -- |
| Issuance of Common Stock | -- | 5,409.89% | 1,059.93% | -90.84% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 5,409.89% | 100.77% | 37.49% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.05% | 89.64% | -2,555.38% | 65.11% | -135.63% |